Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer

Xin An, Pei-Rong Ding, Yuhong Li, +6

Biomarkers

Plasma Epstein‐Barr virus DNA level strongly predicts survival in metastatic/recurrent nasopharyngeal carcinoma treated with palliative chemotherapy

Xin An, Feng-Hua Wang, Pei-Rong Ding, +5

Cancer

Blood Lymphocyte-to-Monocyte Ratio Identifies High-Risk Patients in Diffuse Large B-Cell Lymphoma Treated with R-CHOP

Zhiming Li, Jia-Jia Huang, Yi Xia, +10

PLoS ONE

Expression and clinical significance of androgen receptor in triple negative breast cancer

Xiang Luo, Yan-Xia Shi, Zhiming Li, +1

Chinese Journal of Cancer

Elimination of stem-like cancer cell side-population by auranofin through modulation of ROS and glycolysis

Guoxin Hou, Panpan Liu, Shengyi Zhang, +7

Cell Death and Disease

Elevated neutrophil to lymphocyte ratio predicts poor prognosis in nasopharyngeal carcinoma

Xin An, Pei-Rong Ding, Feng-Hua Wang, +2

Tumor Biology

Comparison of 6th and 7th AJCC TNM Staging Classification for Carcinoma of the Stomach in China

Miao‐Zhen Qiu, Zhiqiang Wang, Dong-sheng Zhang, +6

Annals of Surgical Oncology

Esophageal CancerGastrointestinal OncologyMedicineHistopathologyGastroenterology +5

Phase II study of capecitabine and cisplatin combination as first-line chemotherapy in Chinese patients with metastatic nasopharyngeal carcinoma

Yuhong Li, Feng-Hua Wang, Wen-Qi Jiang, +7

Cancer Chemotherapy and Pharmacology

MedicineMetronomic TherapyCisplatin CombinationPathologyPhase Ii Study +4

Post-treatment plasma EBV-DNA positivity predicts early relapse and poor prognosis for patients with extranodal NK/T cell lymphoma in the era of asparaginase

Liang Wang, Hua Wang, Jing‐Hua Wang, +5

Oncotarget

Efficacy of combined gemcitabine, oxaliplatin and pegaspargase (P-gemox regimen) in patients with newly diagnosed advanced-stage or relapsed/refractory extranodal NK/T-cell lymphoma

Jing‐Hua Wang, Liang Wang, Cheng‐Cheng Liu, +5

Oncotarget

ImmunologyPathologyImmunotherapyHematological MalignancyOncology +16